Cyclothiazide (Anhydron, Acquirel, Doburil, Fluidil, Renazide, Tensodiural, Valmiran), sometimes abbreviated CTZ, is a benzothiadiazide diuretic and antihypertensive that was originally introduced in the United States in 1963 by Eli Lilly and was subsequently also marketed in …

Like other thiazides, cyclothiazide promotes water loss from the body (diuretics). It inhibits Na + /Cl - reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid.

Cyclothiazide is orally administered and generally well-absorbed from the gastrointestinal tract. Its absorption can vary among individuals but is usually rapid and extensive, with peak plasma concentrations achieved within 1-2 hours after oral administration.

Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either...

Cyclothiazide was presumably developed by Eli Lilly for the treatment of hypertension. It is believed that the drug, which belongs to the class of thiazide diuretics, exerts its action by inhibitin sodium reabsorption in the renal tubules.

Cyclothiazide is a benzothiadiazide belonging to the class of thiazide diuretics. Cyclothiazide is indicated as adjunctive therapy in edema and in the treatment of hypertension.

Cyclothiazide is a benzothiadiazide belonging to the class of thiazide diuretics. Cyclothiazide is indicated as adjunctive therapy in edema and in the treatment of hypertension.

Cyclothiazide is 1,1-dioxide 3,4-dihydro-3- (5-norbornen-2-yl)-6-chloro-2H -1,2,4-benzothiadiazin-7-sulfonamide (21.3.12) [32–34]. Synonyms of this drug are diampres, cyclotheriam, anhydron, and others.

Cyclothiazide (Anhydron, Acquirel, Doburil, Fluidil, Renazide, Tensodiural, Valmiran) is a benzothiadiazide diuretic and antihypertensive that was originally introduced in the United States in 1963 by Eli Lilly and was subsequently also marketed in Europe and Japan.